Sofinnova backs cellulosic glucose platform Comet Biorefining

Comet Biorefining Inc has raised an undisclosed amount of funding. Sofinnova Partners, a French venture capital firm, led the round. Based in London, Ontario, Comet Biorefining is a provider of high-quality, cost-competitive cellulosic glucose technology for applications in renewable biofuels and biochemicals. It said investment proceeds will be used to complete the design of its commercial facility, expand its team and continue to develop commercial partnerships. The company was founded by CTO Dr. Andrew Richard.

25 February 2015•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail